Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-13-043963
Filing Date
2013-05-22
Accepted
2013-05-22 17:30:33
Documents
1
Period of Report
2013-05-21

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3371
  Complete submission text file 0001104659-13-043963.txt   4846
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SEMS CAPITAL 7 DEY STREET, SUITE 1101 NEW YORK NY 10017
Business Address
Sems Lloyd (Reporting) CIK: 0001436850 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 13865771